Skip to content

APOTHEEK TEN VOORDE: what changed

BE 0810.185.174NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€52,994
2024 · €80,387-€27,393
Equity
€220,710
2024 · €217,715+€2,994
Cash
€122,130
2024 · €114,665+€7,465
Balance sheet total
€332,680
2024 · €332,996-€317

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€16,492

    down €16,492 (-20.1%), from €82,111 to €65,620

    of which Other amounts receivable: -€13,183

  • Cash +€7,465

    up €7,465 (+6.5%), from €114,665 to €122,130

    mainly Net result for the year (+€52,994) and Receivables within one year (+€16,492)

  • Stocks and contracts +€5,989

    up €5,989 (+6.2%), from €97,148 to €103,137

Equity and liabilities
  • Other debts -€8,345

    down €8,345 (-10.8%), from €77,000 to €68,655

Income statement
  • Gross operating margin -€16,601

    down €16,601 (-23.0%), from €72,184 to €55,584

  • Financial income -€10,375

    down €10,375 (-76.1%), from €13,637 to €3,262

  • Financial charges -€1,146

    down €1,146 (-39.9%), from €2,872 to €1,727

  • Depreciation +€840

    up €840 (+136%), from €617 to €1,456

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €80,387
Gross operating margin -€16,601
Depreciation -€840
Other operating charges +€387
Other operating items -€1,600
Financial income -€10,375
Financial charges +€1,146
Taxes +€490
Result 2025 €52,994
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€61,563
Investment -€4,098
Financing -€50,000
Cash 2024 €114,665
Net result for the year +€52,994
Depreciation +€1,456
Stocks and contracts -€5,989
Receivables within one year +€16,492
Smaller working-capital items -€5
Trade debts +€3,167
Other debts -€8,345
Accrued charges and deferred income +€1,793
Investment in fixed assets (net) -€3,480
Current investments -€618
Contributions, distributions and other -€50,000
Cash 2025 €122,130
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €332,996 €332,680 -€317 -0.1%
Fixed assets 21/28 €8,476 €10,500 +€2,024 +23.9%
Tangible fixed assets 22/27 €8,476 €10,500 +€2,024 +23.9%
Plant, machinery and equipment 23 €8,476 €10,500 +€2,024 +23.9%
Current assets 29/58 €324,520 €322,180 -€2,340 -0.7%
Stocks and contracts in progress 3 €97,148 €103,137 +€5,989 +6.2%
Stocks 30/36 €97,148 €103,137 +€5,989 +6.2%
Amounts receivable within one year 40/41 €82,111 €65,620 -€16,492 -20.1%
Trade receivables 40 €66,029 €62,721 -€3,308 -5.0%
Other amounts receivable 41 €16,082 €2,899 -€13,183 -82.0%
Current investments 50/53 €29,853 €30,471 +€618 +2.1%
Cash at bank and in hand 54/58 €114,665 €122,130 +€7,465 +6.5%
Deferred charges and accrued income 490/1 €743 €822 +€80 +10.7%
Total equity and liabilities 10/49 €332,996 €332,680 -€317 -0.1%
Equity 10/15 €217,715 €220,710 +€2,994 +1.4%
Contributions 10/11 €18,550 €18,550 = 0.0%
Reserves 13 €199,165 €202,160 +€2,994 +1.5%
Distributable reserves 133 €199,165 €202,160 +€2,994 +1.5%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €115,281 €111,970 -€3,311 -2.9%
Amounts payable within one year 42/48 €115,281 €110,177 -€5,104 -4.4%
Trade debts 44 €38,207 €41,374 +€3,167 +8.3%
Suppliers 440/4 €38,207 €41,374 +€3,167 +8.3%
Taxes, remuneration and social security 45 €74 €148 +€74 +100%
Taxes 450/3 €74 €148 +€74 +100%
Other amounts payable 47/48 €77,000 €68,655 -€8,345 -10.8%
Accrued charges and deferred income 492/3 - €1,793 +€1,793
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €617 €1,456 +€840 +136%
Other operating charges 640/8 €512 €125 -€387 -75.6%
Non-recurring operating charges 66A €0 €1,600 +€1,600
Gross operating margin 9900 €72,184 €55,584 -€16,601 -23.0%
Operating profit (loss) 9901 €71,056 €52,402 -€18,653 -26.3%
Financial income 75/76B €13,637 €3,262 -€10,375 -76.1%
Recurring financial income 75 €13,637 €3,262 -€10,375 -76.1%
Financial charges 65/66B €2,872 €1,727 -€1,146 -39.9%
Recurring financial charges 65 €2,872 €1,727 -€1,146 -39.9%
Profit (loss) for the period before taxes 9903 €81,821 €53,938 -€27,883 -34.1%
Income taxes 67/77 €1,433 €943 -€490 -34.2%
Profit (loss) for the period 9904 €80,387 €52,994 -€27,393 -34.1%
Profit (loss) for the period to be appropriated 9905 €80,387 €52,994 -€27,393 -34.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€365,673 to €467,800

Midpoint €408,226 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €220,710
Capitalised earnings €510,636 to €714,890
Indication €365,673 to €467,800

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€220,710
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€220,710

Capitalised earnings

net result for the year (9904)
2025
€52,994
excluding non-recurring income and charges
€54,594
2024
€80,387
2023
€76,957
excluding non-recurring income and charges
€79,486
2022
€25,925
2021
€76,148
Average result, excluding non-recurring income and charges
€71,489
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€510,636 / €595,742 / €714,890

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.